We first analyzed the expression level of GPR84 across cancers and found that the expression level of GPR84 was higher in glioma, breast cancer, liver cancer, lung cancer, pancreatic cancer and stomach cancer than in normal tissues (Figures 5C,D). This evidence concerns the gene GPR84 and central nervous system cancer.